Bretylium Compounds
- Name
- Bretylium Compounds
- Accession Number
- DBCAT001283
- Description
Benzylammonium compounds with the formula Br-phenyl-CN+R3 that include BRETYLIUM TOSYLATE.
- Drugs
Drug Drug Description Bretylium A norepinephrine release inhibitor used for the prophylaxis and therapy of ventricular fibrillation, as well as the treatment of life-threatening ventricular arrhythmias. - Drugs & Drug Targets
Drug Target Type Bretylium Sodium/potassium-transporting ATPase subunit alpha-1 target